Tara Cain

Ms. Tara Cain

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TCTara Cain
Tara Cain
JBJacinta Brinsley
Jacinta Brinsley
HBHunter Bennett
Hunter Bennett
MNMax Nelson
Max Nelson
CMCarol Maher
Carol Maher
BSBen Singh
Ben Singh
Background: Cold-water immersion (CWI) has gained popularity as a health and wellbeing intervention among the general population. Objective: This systematic review and meta-analysis aimed to evaluate the psychological, cognitive, and physiological effects of CWI in healthy adults. Methods: Electronic databases were searched for randomized trials involving healthy adults aged ≥ 18 years undergoing acute or long-term CWI exposure via cold shower, ice bath, or plunge with water temperature ≤15°C for at least 30 seconds. Outcomes of interest were sleep, stress, fatigue, energy, skin health, immunity, inflammation, mental wellbeing, depression, anxiety, mood, concentration, and alertness or focus. Meta-analyses were conducted using RevMan software (version 5.4), applying random effects models to calculate standardized mean differences (SMD) between pre- and post-CWI exposure outcomes. Risk of bias was assessed using the PEDro scale. Results: Eleven studies were included, comprising 3177 total participants and a mean PEDro score of 6.4 (n = 7 moderate quality, n = 4 high quality). CWI interventions were performed in baths (n = 10) or showers (n = 1) at temperatures ranging from 7°C to 15°C and durations ranging from 30 seconds to 2 hours. The meta-analysis revealed significant increases in inflammation immediately (SMD: 1.03, [95% CI: 0.37, 1.68], p < 0.01) and 1 hour post CWI (SMD: 1.26, [95% CI: 0.59, 1.94], p < 0.01), indicating an acute inflammatory response. A significant reduction in stress was observed 12 hours post-CWI (SMD: –1.00, [95% CI: –1.40, –0.61], p < 0.01), however, no significant effects on stress were detected immediately (SMD: –0.09 [95% CI: –0.45, 0.63], p > 0.05), 1 hour (SMD: –0.29 [95% CI: –0.66, 0.08], p > 0.05), 24 hours (SMD: –0.06 [95% CI: –0.50, 0.38], p > 0.05), or 48 hours (SMD: 0.09 [95% CI: –0.28, 0.46], p > 0.05) post-exposure. While meta-analysis showed no significant effects on immune function immediately (SMD: –0.16 [95% CI: –0.82, 0.51], p > 0.05) or 1 hour (SMD: –0.18 [95% CI: –1.09, 0.74], p > 0.05) post-CWI, narrative synthesis suggested longer-term benefits, including a 29% reduction in sickness absence among participants who took cold showers. Improvements were also observed in sleep quality and quality of life, but not mood. Conclusions: This systematic review suggests that CWI delivers time-dependent effects on inflammation, stress, immunity, sleep quality, and quality of life, offering potential practical applications for health practitioners considering CWI for stress management and wellbeing support. However, the current evidence base is constrained by few RCTs, small sample sizes, and a lack of diversity in study populations. Future high-quality RCTs are needed to examine the long-term effects of CWI, its impact on diverse health outcomes, and optimal CWI protocols. PROSPERO (ID: CRD42024500591)

22 May 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
KSKimberley Szeto
Kimberley Szeto
CMCarol Maher
Carol Maher
RCRachel G. Curtis
Rachel G. Curtis
BSBen Singh
Ben Singh
TCTara Cain
Tara Cain
TFTy Ferguson
Ty Ferguson
Background/Objectives: Wearable activity trackers (WATs) are increasingly used by individuals to monitor physical activity, sleep, and other health behaviors. Integrating WAT data into clinical care may offer a cost-effective strategy to support health behavior change. However, little is known about users’ willingness to share their WAT data with healthcare providers. This study aimed to explore attitudes and experiences of WAT users regarding the sharing of WAT data with healthcare providers and to examine how these vary according to user characteristics. Methods: An international online cross-sectional survey was conducted on adults who had used a WAT within the past three years. The survey assessed user demographics, usage patterns, experiences of sharing data with healthcare providers, and willingness or concerns regarding data sharing. Multivariate logistic regression was used to examine associations between user characteristics and data-sharing experiences or attitudes. Results: 447 participants completed the survey (60.0% female; 83.9% < 45 years; 60.0% from the United States). Most (94%) participants expressed willingness to share WAT data with healthcare providers, 47% had discussed it, and 43% had shared WAT data in clinical settings. Privacy was the most commonly reported concern, cited by 10% of participants. Participants with chronic health conditions were more likely to have shared or discussed WAT data, but also more likely to report concerns. Geographic differences were also observed, with Australian participants less likely to have shared or discussed their WAT data with providers, and US participants reporting fewer privacy concerns. Conclusions: The high willingness to share WAT data suggests that there is a possibility for integrating patient-owned WATs into clinical care. Addressing privacy concerns and equipping healthcare professionals with the skills to use WAT data will be essential to fully realize this opportunity. These findings highlight the need for further development of secure WAT systems, clinician training, and expanded evidence on WATs’ clinical utility.